Replies to post #108946 on Amarantus Bioscience Holdings Inc (AMBS)

[shamalam]

Below .06 is your call now, wow sol your drooling, manners man

[joboggi]

There is no doubt. Positive data, and it pops, negative data and it drops. easy.

It will be an inflection point. The chart says the market is NOT anticipating positive data. I am open minded, but based on the previous data, I do not expect to be wowed.

Regardless, a study with 36 People with AD is useless at this stage of development. The thinking behind why folks will use Lympro is totally flawed, and this thing is just pretty interesting.

A negative or positive study does not tell you much because there are not enough people in the study. Go back to Dr. Kriby's presentation and watch his face when he talks about the number of people in a study, and look at any generally accepted study and there are FAR more than 36 people with the disease in the study, especially with a disease as common as AD.

So, no changes from AMBS on the real science front. They keep rolling out studies that are too small to even consider being science.

Laughable.

[Skeetz99]

Already confirmed that Univariate data can only go higher from previously reported numbers. Minimally, it will be at least in the 80% range and possibly 90% +.

Where do you people come from exacty.....basically, you are calling GC a Liar. Its amazing how many here are lazy and make misleading statements constantly.

[sante1]

Solantey, I believe you have faith in the concept of AMBS just like I do.
I does it mean personal but we all know that the shareprices of every upcoming biotech company falls or goes up depending on the announcements they make. So far nothing new here.

What will it be?
Gerald has told us many times already that Lympro will be on the Market next year. I think the man is trustworthy. Why? I can't imagine he puts his good reputation at stake at this very early stage of truth for AMBS right now.
Gerald is trying to run the business independently as long as possible. That's also good for us.

I expect good numbers and at what time exactly Lympro will be in the Market,is not so important, in my believe. Not too late I hope.
Good numbers gives AMBS the possibility to generate income and to stay longer independant at least for the upcoming two years and is of course good for the shareprice.

I's all a question of believing or disbelieving, that's biotechland.

What do we think it will be? More reactions please.

[Shark Attack]

Giving you a round of applause basically for as long as I can remember you've been long AMBS.

[Solantey]

The share price is doing exactly as I thought it would leading up to the release of the LymPro data.

I have a very good idea as to what to expect next week and how the share price will react.

There are number of AMBS "whales" who aren't going to like what happens to the share price next week.

I never thought the share price could go below .06 again but I have reasonable expectation that it will happen.

As I stated before it wouldn't surprise me if L.P.C. is actually shorting shares through an affiliate knowing that they can potentially buy shares for as low as four cents to cover.

The additional one billion shares are there for a reason and it's not to prevent a hostile takeover.

Remember there were millions of shares bought above .10 that are now being held at a loss and the holders of those shares will sell into any upward movement on the share price in an attempt to minimize their losses.

Interesting week ahead.

p.s. I have a target price.